Literature DB >> 35594413

Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2.

Kaifu Gao1, Rui Wang1, Jiahui Chen1, Limei Cheng2, Jaclyn Frishcosy1, Yuta Huzumi1, Yuchi Qiu1, Tom Schluckbier1, Xiaoqi Wei1, Guo-Wei Wei1,3,4.   

Abstract

Despite tremendous efforts in the past two years, our understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), virus-host interactions, immune response, virulence, transmission, and evolution is still very limited. This limitation calls for further in-depth investigation. Computational studies have become an indispensable component in combating coronavirus disease 2019 (COVID-19) due to their low cost, their efficiency, and the fact that they are free from safety and ethical constraints. Additionally, the mechanism that governs the global evolution and transmission of SARS-CoV-2 cannot be revealed from individual experiments and was discovered by integrating genotyping of massive viral sequences, biophysical modeling of protein-protein interactions, deep mutational data, deep learning, and advanced mathematics. There exists a tsunami of literature on the molecular modeling, simulations, and predictions of SARS-CoV-2 and related developments of drugs, vaccines, antibodies, and diagnostics. To provide readers with a quick update about this literature, we present a comprehensive and systematic methodology-centered review. Aspects such as molecular biophysics, bioinformatics, cheminformatics, machine learning, and mathematics are discussed. This review will be beneficial to researchers who are looking for ways to contribute to SARS-CoV-2 studies and those who are interested in the status of the field.

Entities:  

Mesh:

Year:  2022        PMID: 35594413      PMCID: PMC9159519          DOI: 10.1021/acs.chemrev.1c00965

Source DB:  PubMed          Journal:  Chem Rev        ISSN: 0009-2665            Impact factor:   72.087


  1105 in total

1.  CLUSTAL: a package for performing multiple sequence alignment on a microcomputer.

Authors:  D G Higgins; P M Sharp
Journal:  Gene       Date:  1988-12-15       Impact factor: 3.688

2.  Extending the identification of structural features responsible for anti-SARS-CoV activity of peptide-type compounds using QSAR modelling.

Authors:  V H Masand; V Rastija; M K Patil; A Gandhi; A Chapolikar
Journal:  SAR QSAR Environ Res       Date:  2020-08-27       Impact factor: 3.000

3.  Mechanistic Insights into SARS-CoV-2 Main Protease Inhibition Reveals Hotspot Residues.

Authors:  Parthiban Marimuthu; Suresh Gorle; Konda Reddy Karnati
Journal:  J Chem Inf Model       Date:  2021-11-29       Impact factor: 6.162

4.  Black tea bioactives as inhibitors of multiple targets of SARS-CoV-2 (3CLpro, PLpro and RdRp): a virtual screening and molecular dynamic simulation study.

Authors:  Madhurjya Gogoi; Meghali Borkotoky; Sangeeta Borchetia; Pritom Chowdhury; Saurov Mahanta; Anoop Kumar Barooah
Journal:  J Biomol Struct Dyn       Date:  2021-03-10       Impact factor: 5.235

5.  High-throughput rational design of the remdesivir binding site in the RdRp of SARS-CoV-2: implications for potential resistance.

Authors:  Aditya K Padhi; Rohit Shukla; Prakash Saudagar; Timir Tripathi
Journal:  iScience       Date:  2020-12-26

6.  Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study.

Authors:  Manab Mandal; Swapan Kumar Chowdhury; Abdul Ashik Khan; Nabajyoti Baildya; Tanmoy Dutta; Debabrata Misra; Narendra Nath Ghosh
Journal:  J Mol Struct       Date:  2021-02-26       Impact factor: 3.196

7.  Prediction of potential inhibitors of SARS-CoV-2 using 3D-QSAR, molecular docking modeling and ADMET properties.

Authors:  Ayoub Khaldan; Soukaina Bouamrane; Fatima En-Nahli; Reda El-Mernissi; Khalil El Khatabi; Rachid Hmamouchi; Hamid Maghat; Mohammed Aziz Ajana; Abdelouahid Sbai; Mohammed Bouachrine; Tahar Lakhlifi
Journal:  Heliyon       Date:  2021-03-26

8.  Seq12, Seq12m, and Seq13m, peptide analogues of the spike glycoprotein shows antiviral properties against SARS-CoV-2: An in silico study through molecular docking, molecular dynamics simulation, and MM-PB/GBSA calculations.

Authors:  Kunal Dutta; Ammar D Elmezayen; Anas Al-Obaidi; Wei Zhu; Olga V Morozova; Sergey Shityakov; Ibrahim Khalifa
Journal:  J Mol Struct       Date:  2021-07-16       Impact factor: 3.196

9.  Synthesis of novel coumarin analogues: Investigation of molecular docking interaction of SARS-CoV-2 proteins with natural and synthetic coumarin analogues and their pharmacokinetics studies.

Authors:  Sathishkumar Chidambaram; Mohamed A El-Sheikh; Ahmed H Alfarhan; Surendrakumar Radhakrishnan; Idhayadhulla Akbar
Journal:  Saudi J Biol Sci       Date:  2020-11-12       Impact factor: 4.219

View more
  3 in total

1.  SARS-CoV-2 Omicron Variant Binds to Human Cells More Strongly than the Wild Type: Evidence from Molecular Dynamics Simulation.

Authors:  Hoang Linh Nguyen; Nguyen Quoc Thai; Phuong H Nguyen; Mai Suan Li
Journal:  J Phys Chem B       Date:  2022-06-20       Impact factor: 3.466

2.  Perspectives on SARS-CoV-2 Main Protease Inhibitors.

Authors:  Kaifu Gao; Rui Wang; Jiahui Chen; Jetze J Tepe; Faqing Huang; Guo-Wei Wei
Journal:  J Med Chem       Date:  2021-11-19       Impact factor: 8.039

3.  A Novel 3-Gene Signature for Identifying COVID-19 Patients Based on Bioinformatics and Machine Learning.

Authors:  Guichuan Lai; Hui Liu; Jielian Deng; Kangjie Li; Biao Xie
Journal:  Genes (Basel)       Date:  2022-09-08       Impact factor: 4.141

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.